LAMB2 and amyotrophic lateral sclerosis: Significant (p = 0.001–0.003) increases of analyzed markers were determined in both cell-treated versus media-treated ALS mice: hBM34+ cell treated (pericyte: 4.62 ± 0.18%; laminin: 4.18 ± 0.17%); hBM-EPC treated (pericyte: 6.31 ± 0.23%; laminin: 5.57 ± 0.14%; Fig. 2B).